497 related articles for article (PubMed ID: 27258508)
1. Identification of High-Risk Subgroups of Patients With Oral Cavity Cancer in Need of Postoperative Adjuvant Radiotherapy or Chemo-Radiotherapy.
Chen WC; Lai CH; Fang CC; Yang YH; Chen PC; Lee CP; Chen MF
Medicine (Baltimore); 2016 May; 95(22):e3770. PubMed ID: 27258508
[TBL] [Abstract][Full Text] [Related]
2. Postoperative adjuvant therapy for patients with loco-regionally advanced oral squamous cell carcinoma who are at high risk of recurrence.
Yanamoto S; Denda Y; Ota Y; Hasegawa T; Akashi M; Okura M; Yamada SI; Kurita H; Yamakawa N; Kirita T; Ueda M; Umeda M;
Int J Oral Maxillofac Surg; 2020 Jul; 49(7):848-853. PubMed ID: 31926824
[TBL] [Abstract][Full Text] [Related]
3. Postoperative concomitant chemoradiotherapy improved treatment outcomes of patients with oral cavity cancer with multiple-node metastases but no other major risk factors.
Fan KH; Lin CY; Kang CJ; Lee LY; Huang SF; Liao CT; Chen IH; Ng SH; Wang HM; Chang JT
PLoS One; 2014; 9(2):e86922. PubMed ID: 24586259
[TBL] [Abstract][Full Text] [Related]
4. Effects of postoperative chemotherapy and radiotherapy on patients with squamous cell carcinoma of the oral cavity and multiple regional lymph node metastases.
Takahashi H; Yanamoto S; Yamada S; Umeda M; Shigeta T; Minamikawa T; Shibuya Y; Komori T; Shiraishi T; Asahina I; Yokoo S; Ri S
Int J Oral Maxillofac Surg; 2014 Jun; 43(6):680-5. PubMed ID: 24387949
[TBL] [Abstract][Full Text] [Related]
5. Multicenter Retrospective Study of Adjuvant Therapy for Patients with Pathologically Lymph Node-Positive Oral Squamous Cell Carcinoma: Analysis of Covariance Using Propensity Score.
Yanamoto S; Otsuru M; Ota Y; Okura M; Aikawa T; Kurita H; Kamata T; Kirita T; Yamakawa N; Ueda M; Yamashita T; Komori T; Shigeta T; Yokoo S; Ogawa M; Umeda M;
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S992-9. PubMed ID: 26289809
[TBL] [Abstract][Full Text] [Related]
6. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival.
Brandwein-Gensler M; Teixeira MS; Lewis CM; Lee B; Rolnitzky L; Hille JJ; Genden E; Urken ML; Wang BY
Am J Surg Pathol; 2005 Feb; 29(2):167-78. PubMed ID: 15644773
[TBL] [Abstract][Full Text] [Related]
7. Postoperative radiotherapy with or without concurrent chemotherapy for oral squamous cell carcinoma in patients with three or more minor risk factors: a propensity score matching analysis.
Fan KH; Chen YC; Lin CY; Kang CJ; Lee LY; Huang SF; Liao CT; Ng SH; Wang HM; Chang JT
Radiat Oncol; 2017 Nov; 12(1):184. PubMed ID: 29166942
[TBL] [Abstract][Full Text] [Related]
8. Association Between Lymph Node Ratio and Recurrence and Survival Outcomes in Patients With Oral Cavity Cancer.
Ding D; Stokes W; Eguchi M; Hararah M; Sumner W; Amini A; Goddard J; Somerset H; Bradley C; McDermott J; Raben D; Karam SD
JAMA Otolaryngol Head Neck Surg; 2019 Jan; 145(1):53-61. PubMed ID: 30452499
[TBL] [Abstract][Full Text] [Related]
9. Treatment results of postoperative radiotherapy on squamous cell carcinoma of the oral cavity: coexistence of multiple minor risk factors results in higher recurrence rates.
Fan KH; Wang HM; Kang CJ; Lee LY; Huang SF; Lin CY; Chen EY; Chen IH; Liao CT; Chang JT
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1024-9. PubMed ID: 20610038
[TBL] [Abstract][Full Text] [Related]
10. Lymph node ratio relationship to regional failure and distant metastases in oral cavity cancer.
Hosni A; McMullen C; Huang SH; Xu W; Su J; Bayley A; Bratman SV; Cho J; Giuliani M; Kim J; Ringash J; Waldron J; Spreafico A; Weinreb I; de Almeida JR; Brown DH; Irish JC; O'Sullivan B; Goldstein DP; Hope A
Radiother Oncol; 2017 Aug; 124(2):225-231. PubMed ID: 28838425
[TBL] [Abstract][Full Text] [Related]
11. Definitive (chemo)radiotherapy is a curative alternative for standard of care in advanced stage squamous cell carcinoma of the oral cavity.
Elbers JBW; Al-Mamgani A; Paping D; van den Brekel MWM; Jóźwiak K; de Boer JP; Karakullukcu B; Verheij M; Zuur CL
Oral Oncol; 2017 Dec; 75():163-168. PubMed ID: 29224815
[TBL] [Abstract][Full Text] [Related]
12. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
[TBL] [Abstract][Full Text] [Related]
13. [Outcome and prognostic factors of 125 loco-regionally advanced head and neck squamous cell carcinoma treated with multi-modality treatment].
Qian W; Zhu G; Ji Q; Guo Y; Wang Y; Wang Y
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):217-22. PubMed ID: 24785284
[TBL] [Abstract][Full Text] [Related]
14. Multi-center retrospective study of the prognosis and treatment outcomes of Japanese oral squamous cell carcinoma patients with single lymph node metastasis and extra nodal extension.
Hasegawa T; Yanamoto S; Otsuru M; Kakei Y; Okura M; Yamakawa N; Yamada SI; Ota Y; Umeda M; Kirita T; Kurita H; Ueda M; Komori T;
J Surg Oncol; 2018 Jun; 117(8):1736-1743. PubMed ID: 29714825
[TBL] [Abstract][Full Text] [Related]
15. Postoperative radiotherapy for patients at high risk of recurrence of oral cavity squamous cell carcinoma.
Herman MP; Dagan R; Amdur RJ; Morris CG; Werning JW; Vaysberg M; Mendenhall WM
Laryngoscope; 2015 Mar; 125(3):630-5. PubMed ID: 25376116
[TBL] [Abstract][Full Text] [Related]
16. Clinical Outcomes in pT4 Tongue Carcinoma are Worse than in pT3 Disease: How Extrinsic Muscle Invasion Should be Considered?
Liao CT; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Hsieh CH; Ng SH; Lin CH; Tsao CK; Kang CJ; Fang TJ; Huang SF; Chang KP; Yang LY; Yen TC
Ann Surg Oncol; 2017 Sep; 24(9):2570-2579. PubMed ID: 28577181
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors Associated with Disease Recurrence in Patients with Stage III/IV Squamous Cell Carcinoma of the Oral Cavity Treated with Surgery and Postoperative Radiotherapy.
Noble AR; Greskovich JF; Han J; Reddy CA; Nwizu TI; Khan MF; Scharpf J; Adelstein DJ; Burkey BB; Koyfman SA
Anticancer Res; 2016 Feb; 36(2):785-92. PubMed ID: 26851040
[TBL] [Abstract][Full Text] [Related]
18. [Curative effect analysis of postoperative concurrent chemoradiotherapy on early-stage cervical cancer patients with intermediate-risk factors].
Tang Q; Tu YQ; Chen JH; Lyu XJ; Yan DD
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):462-466. PubMed ID: 29936774
[No Abstract] [Full Text] [Related]
19. The Therapeutic Benefit of Radical Resection for T4b Oral Cavity Squamous Cell Carcinoma with Partial or Complete Response After Radical Chemo-Intensity-Modulated Radiotherapy (IMRT).
Fang FM; Chuang HC; Chou SY; Huang TL; Wang CJ; Lin YT; Chiu TJ; Lin WC; Li SH; Su YY; Chien CY
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):866-873. PubMed ID: 27613559
[TBL] [Abstract][Full Text] [Related]
20. Survival in squamous cell carcinoma of the oral cavity: differences between pT4 N0 and other stage IVA categories.
Liao CT; Chang JT; Wang HM; Ng SH; Hsueh C; Lee LY; Lin CH; Chen IH; Huang SF; Cheng AJ; Yen TC
Cancer; 2007 Aug; 110(3):564-71. PubMed ID: 17577219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
